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Abstract
Background: SM22 has long been studied as an actin-associated protein. Interestingly, levels of SM22 are often
reduced in tumour cell lines, while they are increased during senescence possibly indicating a role for SM22 in cell
fate decisions via its interaction with actin. In this study we aimed to determine whether reducing levels of SM22
could actively contribute to a tumourigenic phenotype.
Results: We demonstrate that in REF52 fibroblasts, decreased levels of SM22 disrupt normal actin organization
leading to changes in the motile behaviour of cells. Interestingly, SM22 depletion also led to an increase in the
capacity of cells to spontaneously form podosomes with a concomitant increase in the ability to invade Matrigel.
In PC3 prostate epithelial cancer cells by contrast, where SM22 is undetectable, re-expression of SM22 reduced the
ability to invade Matrigel. Furthermore SM22 depleted cells also had reduced levels of reactive oxygen species
when under serum starvation stress.
Conclusions: These findings suggest that depletion of SM22 could contribute to tumourigenic properties of cells.
Reduction in SM22 levels would tend to promote cell survival when cells are under stress, such as in a hypoxic
tumour environment, and may also contribute to increases in actin dynamics that favour metastatic potential.
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Background
Smooth muscle protein of 22kDa (SM22a) was one of
three protein isoforms (a,b,g) first purified from chicken
gizzard muscle but with no known function [1]. Several
years later SM22 was rediscovered and named transgelin
due to its apparent ability to induce gelation of actin
filaments in vitro [2] however subsequent analysis
revealed that SM22 and transgelin were one and the
same protein [3,4]. These and subsequent analyses have
identified a family of related proteins variously known
as mp20, NP22, NP25, p27, SM22a, SM22b, transgelin
and WS3-10 (see [5] for brief review). Following the
sequencing of various vertebrate genomes, it is now
recognized that all these proteins arise from just three
genes named TAGLN1-3, with SM22a, transgelin and
WS3-10 being independently discovered, but identical
products of the TAGLN1 gene, SM22b the product of
TAGLN2 and the neuronally expressed NP22 and NP25
the product of TAGLN3. SM22 is a member of the cal-
ponin family of proteins [6] all of which comprise an
amino-terminal calponin homology (CH) domain and
from one (SM22) to three (calponin) short motifs know
as calponin or CLIK23 repeats [7]. All family members
are actin binding and under some circumstances actin
bundling proteins. Despite the presence of a CH
domain, actin binding is not mediated by the CH
domain [8] but through sequences between the CH
domain and the first calponin repeat and within the cal-
ponin repeats themselves (reviewed in [9]). SM22 ortho-
logues in invertebrates have also been described
including mp20 in Drosophila and Scp1p in S. cerevisiae
[10-12]. Unlike the situation in vertebrates with three
TAGLN genes, in S. cerevisiae Scp1p is the sole SM22/
transgelin representative. Studies on Scp1 have shown
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that deletion of scp1 enhances cell longevity through an
increase in F-actin turnover and a drop in levels of cell
reactive oxygen species. Conversely, increased levels of
Scp1 led to decreased actin dynamics, an increase in cel-
lular levels of reactive oxygen species and increased cell
death [13]. In addition, it has been observed that SM22
levels are elevated in senescent mammalian cells sug-
gesting that the role of the interaction characterized
between Scp1 and actin in yeast may play a similar role
in higher eukaryotes [14-16]. We therefore investigated
the relationship between SM22/transgelin and the orga-
nization of the actin cytoskeleton, cell migration and
response to stress in fibroblast and prostate cancer cell
lines.
Results
Expression of SM22/transgelin family products in cell
lines
Most vertebrate genomes contain 3 TAGLN genes and
many tissues and cells express more than one gene. In
order to examine the function of single TAGLN gene
products and to increase the chances of being able to
deplete all TAGLN gene products in a given cell, we
made an initial screen of cell lines from different tissue
sources in order to determine what complement of
TAGLN gene products were expressed. After analyzing
cell lines of fibroblast, muscle, neuronal and epithelial
origin, we selected the rat embryo fibroblast cell line
REF52 as suitable for further study. This was not only
due to its flattened morphology and well organized actin
stress fibre morphology that would aid morphological
characterization of effects on the actin cytoskeleton, but
also based on western blotting showing the presence of
only one of the TAGLN gene products namely SM22a
(Figure 1A). In keeping with previous reports that SM22
is an F-actin binding/bundling protein, both the endo-
genous SM22a, revealed by specific antibody staining,
and an exogenous SM22a-GFP construct localized
strongly with the prominent F-actin containing stress
fibres in these cells (Figure 1B-G).
Depleting SM22 expression levels alters actin
organization
In order to further dissect the role of SM22, we used
siRNA-mediated SM22 depleted REF52 cells to investi-
gate the contribution of SM22 to the actin morphology.
Depletion of SM22 to between 20% and 40% of normal
levels resulted in a dramatic and reproducible change in
actin stress fibre morphology (Figure 2 and Additional
file 1, Figure S1). In clones of REF52 cells depleted for
SM22, using either REF52 stably expressing siRNA con-
structs directed against SM22 (Additional file 1, Figure
S1) or transient RNAi expression driven from a pSiren-
DNR-dsRed plasmid (Figure 2), there was a reproducible
and qualitatively similar reduction in SM22 with conco-
mitant loss of actin stress fibre organization. In greater
than 70% of wild-type cells actin was organized in
longer relatively parallel arrays of fibres, the typical mor-
phology for this cell type (Figure 2A, B). However, in
two independent clones (Knockdown A and B; Figure 2)
of SM22 depleted cells there was a significant increase
in the proportion of cells observed with shorter and
orthogonal arrays of actin fibres. These cells also had a
marked increase in the proportion of cells with no
apparent stress fibres. See insets in Figure 2A for detail
of the phenotypes. These observations demonstrate that
SM22 has a significant role in the organization of the
actin cytoskeleton, and that reduction in SM22 levels
leads to a less bundled, less well organized and poten-
tially more dynamic actin cytoskeleton.
Migration, chemotaxis and invasion in SM22 depleted
cells
Given the importance of the actin cytoskeleton in cell
motility, and that SM22 levels appear altered in tumour
cells that often have altered migratory properties, we
next investigated the effect of reducing SM22 levels on
various in vitro measures of cell migration, chemotaxis
Figure 1 Expression and localization of transgelin family
proteins in REF52 cells. A, western blot analysis of SM22, NP25
and NP22 levels in various cell lines as indicated (S3T3 = Swiss 3T3).
REF52 cells were chosen for further analysis due to their amenable
phenotype and the expression of only SM22a. B-G, REF52 cells
stained with Alexa 488 phalloidin (red in merge) to reveal F-actin
containing structures (B, E), and stained for endogenous SM22a (C),
or expressing SM22a-GFP (F) green in merges. Merged images (D,
G) all show strong co-localization between endogenous and
exogenous SM22 proteins and F-actin stress fibres. Nucleus
counterstained with DAPI (blue).
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and invasion. For improved consistency of cellular
response in these experiments REF52 cells stably expres-
sing shRNA were used with a resulting 50% depletion of
SM22 compared to sense control (Figure 3A). Single cell
tracking of individual SM22 depleted cells revealed that
the SM22 depleted cells showed impaired movement
with considerably reduced trajectories compared to the
sense control. This data was then used to calculate cellu-
lar velocities, and as expected revealed that both SM22
depleted clones had significantly reduced average velocity
compared to that of the sense control (Figure 3D). Simi-
lar effects on cell migration have been noted for vascular
smooth muscle cells depleted for SM22 [17].
We also analyzed whether there was a change in chemo-
tactic response in SM22 depleted cells. Loss of actin orga-
nization can affect not only the mechanics of cell
migration, but also cell polarity, which is required for pro-
ductive directional migration. Cells exposed to a serum
gradient in a Dunn chamber assay showed no significant
defect in their chemotactic response, indeed Clone 1B
appeared to have a higher persistence ratio than wildtype
cells (Figure 4A) but nonetheless still migrated a shorter
distance. However, motility assays carried out on rigid
two-dimensional substrates do not always reflect the moti-
lity and invasion of cells in three dimensions which would
be more analogous to the in vivo situation. We therefore
exposed SM22 depleted cells to a chemotactic gradient in
Matrigel coated Boyden chambers. Interestingly, in this
environment the SM22 depleted cells were able to invade
and migrate through the Matrigel much more readily than
the control cells (Figure 4B). Therefore despite the inabil-
ity to migrate and the relative lack of responsiveness to
chemotactic stimuli on hard two-dimensional substrates,
SM22 depleted cells appear to be much more effective at
migrating through soft substrates in response to a similar
chemotactic stimulus.
Podosomes form spontaneously in SM22 depleted cells
Podosomes, and the related structures invadopodia, are
typically found in macrophages, osteoclasts and tumour
Figure 2 SM22a depletion alters stress fibre organization. Examples of the ‘normal’ ‘orthogonal’ and ‘absent’ stress fibre phenotypes in
response to depletion of SM22 in REF52 cells. dsRed marks the cells expressing the RNAi, and actin stress fibres are visualized with FITC
phalloidin, insets represent examples of the actin phenotypes described (A). Quantification of the stress fibre phenotype shows that depletion of
SM22a in two independent cell lines leads to a reduction in normal stress fibres and an increase in the cells falling into the ‘orthogonal’ or
‘absent’ categories compared to cells expressing a scrambled RNAi sequence (B). C, quantification of the extent of SM22a depletion by ratio to
tubulin content by western blotting in REF52 cells as a % of a mock transfected control (dsRed empty vector). The scrambled RNAi did not
deplete SM22a compared to control whereas two independent dsRed SM22a RNAi lines of cells, knockdown A and knockdown B, showed a
significant reduction of SM22a levels to 40 and 30% respectively. Mean ± SEM of 3 independent experiments; * p < 0.05 as compared to
scrambled control in all cases in B and C.
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cells and are not usually seen in other mesenchymal
cells unless transformed for example with active Src
[18]. Smooth muscle cells and myoblasts however, have
been shown to form podosomes under certain non-
transformed conditions, including following phorbol
ester or TGF-b stimulation [19-22]. On examining the
actin staining pattern of SM22 depleted cells in more
detail, we noted in addition to the change from the pro-
minent stress fibre phenotype seen in wild type and
control REF52 cells, to the less organized actin mor-
phology of SM22 depleted cells (Figure 2), peripheral
bands of diffuse F-actin staining and dense puncta of F-
actin were now observed with higher frequency (Figure
5A, B). These F-actin puncta and diffuse clouds of F-
actin are reminiscent of podosomes and F-actin rosettes
seen in other migratory and invasive cells. Quantifica-
tion of these additional actin phenotypes demonstrated
that there was a increase in both lamellipodial rosettes
and/or spontaneous podosome formation in cells
depleted for SM22 (Figure 5C) although only the
increase in peripheral actin bands was significant. These
findings demonstrate a further change in cellular actin
structures in response to SM22 depletion. The relatively
static stress fibre phenotype with associated focal adhe-
sions changes to a more dynamic F-actin based adhesion
system is seen by the appearance of more podosomes
and rosettes in SM22 depleted cells.
Depleting SM22 expression levels alters levels of reactive
oxygen species
Deletion of the SM22 homologue in yeast leads to
increased actin dynamics and reduced levels of reactive
Figure 3 Effect of SM22a depletion on cell motility. Stable
depletion of SM22a by expressing shRNA achieved 57% knockdown
in REF52 cell Clone 1B, compared to cells expressing a control sense
RNA hairpin (A). Cell migration was inhibited in SM22 knockdown
cells, single cell trajectories were reduced in Clone 1B compared to
sense control (C), which was matched by a significant reduction in
average velocity (D). Data shown are mean ± SEM in A, C. A n = 3,
p < 0.05 compared to Sense, C n = 20, p < 0.02 compared to
Sense.
Figure 4 SM22a depletion results in increased cell migration/
invasion. Despite a reduction in cell velocity REF52 cells depleted
for SM22a were able to respond to a serum gradient in Dunn
chemotaxis chamber assays (A). However, in invasion assays in
Matrigel-coated Boyden chamber assays SM22 depleted cells
exhibited a significantly enhanced capacity to invade (B; mean ±
SEM 3 independent experiments, * p < 0.01 compared to sense
control).
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oxygen species [13]. Here we describe SM22 depletion
having an effect on actin organization by reducing pro-
minent stress fibres to a more disorganized array (Figure
2) also suggestive of an increase in actin dynamics, with
further evidence of an increase in actin dynamics
revealed by the appearance of podosomes (Figure 5). In
addition, invasive motility is also increased. A concomi-
tant reduction in reactive oxygen species would poten-
tially allow a cell depleted for SM22 to have an
increased survival advantage in a hypoxic tumour envir-
onment. In order to test whether deleted SM22 levels
would also lead to changes in cell’s levels of reactive
oxygen species, we subjected REF52 cells, either normal
controls or SM22 depleted, to complete serum starva-
tion for either 24 or 48 hours. Serum starvation is a
recognized cellular stress that leads to elevated ROS in
normal and tumour cells ([23,24] and references
therein). As can be seen from Figure 6A, both 24 and
48 h serum starvation induced a greater than 15-fold
increase in ROS levels in control REF52 cells. However,
analysis of ROS levels in SM22 depleted REF52 cells
(Figure 6B), revealed considerably reduced ROS levels at
24 h and 48 h (4-fold and 11-fold lower respectively
than controls). Moreover untreated SM22-depleted cells
had a baseline ROS level one third of wildtype cells.
SM22 depletion per se appears to reduce ROS levels in
REF52 cells, as was seen in yeast when the yeast ortho-
logue Scp1 was deleted [13], but in addition SM22
depletion also appears to be protective against stressful
stimuli that lead to ROS accumulation.
Re-expression of SM22 in prostate tumour cell line PC3
reduces podosome formation
Given that SM22 depletion in REF52 cells had a signifi-
cant effect on actin morphology and increased Matrigel
invasion, and that SM22 is also reduced in many
tumour cells [5,25], we investigated the effect of manip-
ulating SM22 levels in PC3 prostate cancer cells, a cell
type that forms podosomes spontaneously [26]. As
SM22 is not detectable by western blotting in PC3 cells
(data not shown and see [27]), we therefore compared
the ability of normal PC3, and PC3 overexpressing
SM22 to form podosomes and to migrate through
Matrigel coated Boyden chambers. As can be seen in
Figure 7A, SM22 overexpression reduced the ability of
PC3 cells to migrate through Matrigel in response to a
serum gradient. Podosomes were detected using
Figure 5 REF52 cells depleted for SM22 have an altered actin
morphology. SM22 depleted cell show an increase in dense actin
puncta reminiscent of podosomes (A), and cells with peripheral
actin bands (B), or both, but only the increase in peripheral actin
bands was statistically significant. Quantitative data shown in C,
represent at least 100 cells counted in each of 5 independent
experiments, mean ± SEM, * p < 0.05 compared to control shRNA.
Black bars, control shRNA, white bars knockdown clone 1B.
Figure 6 SM22 depletion reduces stress induced ROS
production. ROS levels were measured in control REF52 cells (A) or
SM22-depleted REF52-depleted cells (B) in normal serum conditions
or following serum withdrawal for 24 or 48 h. In control REF52 cells
both 24 h or 48 h serum withdrawal resulted in a 15-fold increase
in ROS levels. REF52 cells depleted for SM22 (B) however, had 66%
lower intrinsic ROS levels, and a considerably reduced ROS response
to serum withdrawal for 24 h or 48 h (4-fold and 11-fold increase
over untreated respectively). Control cell population is shaded in
black, 24 and 48 serum withdrawal populations (24SW and 48SW)
are indicated by black or grey lines respectively.
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antibodies to a podosome component cortactin. PC3
cells can be seen to exhibit prominent ruffling mem-
branes and podosomes (Figure 7B-G), as indicated by
co-staining of F-actin and cortactin. However, SM22
expressing PC3 cells had reduced ruffling membranes
and were devoid of podosomes (Figure 7H-J).
Discussion
As we have demonstrated here, modulation in the levels
of SM22 in fibroblast cells alters actin morphology
which in turn affects their adhesion and migration
phenotype. These changes are consistent with increases
or decreases in the overall actin bundling activity in the
cell resulting in decreased or increased actin dynamics
respectively. Studies in yeast have revealed similar con-
sequences for the effects of Scp1p, the yeast homologue
of SM22, in actin dynamics and actin dependent pro-
cesses such as endocytosis [11,12,28]. The actin binding
and bundling activity of SM22 and related proteins is
conferred via sequences c-terminal of the calponin
homology (CH) domain including a short linker peptide
and one to three calponin-like or ‘CLIK23’ repeats [29].
The presence of multiple CLIK repeats can increase the
actin bundling properties of the protein thus stabilizing
the actin cytoskeleton of the cell [29]. By the use of the
C. elegans UNC-87 protein, which contains 7 CLIK
repeats [30], Gimona and colleagues elegantly demon-
strated that expressing increasing numbers of UNC-87
CLIK repeats progressively stabilized the actin cytoskele-
ton and inhibited the cell motility and growth in soft
agar of breast cancer cell lines [29].
Stabilization of the actin cytoskeleton by the overex-
pression of an actin bundling protein might be expected
to have an effect on properties of the cells that rely
upon a dynamic actin cytoskeleton. However, the ability
of CLIK repeat-containing proteins and for SM22 in
particular to achieve this effect appears to be a more
specific function that could be associated with suppres-
sion of the tumour phenotype. Numerous studies have
identified SM22 as being downregulated in cancer
[26,30-35] and some have even gone so far as to claim it
as a tumour suppressor [5]. However, there are contra-
dictory reports suggesting a positive correlation between
an increase in SM22 levels and colon cancer metastasis
to lymph node [31] and increased SM22 levels in gastric
cancer [32], though in the latter study it was acknowl-
edged that this was likely due to SM22 associated with
the increased vascularisation of the tumour rather than
in the tumour cells themselves. Proteomic profiling of
prostate cancer cell lines revealed considerable variation
in levels of SM22 in PC3 and LNCaP cells, even
between different clonal variants of the same cell line
[33]. Similar studies comparing prostate, colorectal and
hepatocellular carcinoma also identified increased levels
of SM22 associated with invasiveness [34].
Whilst the various studies investigating SM22 levels in
different tumours appear to be at odds, one has to con-
sider the cellular basis for the various cancers under
scrutiny. SM22 is normally expressed in mesenchymal
cells and not in epithelial cells, however in tumour cells
undergoing an epithelial to mesenchymal transition
(EMT), it may be that SM22 is re-expressed as a conse-
quence of the adoption of the mesenchymal phenotype.
A similar phenomenon occurs with other epithelial pro-
teins in EMT, such as the E-cadherin to N-cadherin
Figure 7 SM22 re-expression reduces PC3 Matrigel invasion
and podosome formation. Re-expression of SM22 in PC3 cells
reduces significantly the number of cells invading and traversing
the filter in Matrigel coated Boyden chamber assays in response to
a serum gradient (A); mean ± SEM 3 independent experiments, * p
< 0.03 PC3 compared to PC3-SM22 in 0-10% gradient. PC3 cells
stained for F-actin (B, E, H red in merge), cortactin (C, F, I green in
merge). Cells in B-G are control PC3, cell in H-J is expressing SM22.
Normal PC3 exhibit prominent ruffling membranes and podosomes
(arrowed) as indicated by the co-staining of F-actin and cortactin,
whereas SM22 expressing PC3 cells have reduced ruffling
membranes and are devoid of podosomes.
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switch [35]. Therefore differences observed in the levels
of SM22 in different tumours may be a reflection of sev-
eral factors, including the tissue/cell of origin, whether it
is a primary or secondary tumour, the cellular pheno-
type with respect to EMT, the precision of the sampling
of the tumour if it was conducted on a tissue sample,
and/or the relationship between a cell line and the origi-
nal tumour if it is an in vitro study. Therefore SM22
may be upregulated in an adenocarcinoma during EMT,
but downregulated in a sarcoma. Additionally SM22
appears to have a role in regulating transcription, with
some genes being regulated in an SM22-dependent way
[31,36] which could also modulate the tumour pheno-
type. In particular, relief of the repression of the matrix
metalloproteinase MMP9 expression by SM22 in
tumour cells where SM22 is downregulated [36] would
lead to increased MMP9 levels. This could have a signif-
icant impact on cancer progression, especially invasion
and metastasis. Whether the effect of SM22 re-expres-
sion suppressing the Matrigel invasion phenotype of
PC3 cells is a consequence of reduced MMP9 expres-
sion or simply an effect on the dynamics of the actin
cytoskeleton will require further analysis. This coupled
with our observation that a reduction in SM22 levels
also caused an increase in podosome and rosette-like
structures in non-transformed REF52 cells might tend
to argue in favour of SM22 acting as a tumour suppres-
sor [5]. But the lack of a consistent association between
a reduction in SM22 levels and tumour phenotype, and
the contrary evidence of SM22 overexpression reducing
growth in soft agar, [31] would tend to argue against
SM22 being a true tumour suppressor. One additional
explanation for why loss of SM22 might be advanta-
geous in a tumour environment comes from its effect
on the levels of reactive oxygen species (ROS)
[13,37,38]. As we show here, SM22 depletion results in
REF52 cells being less susceptible to stress-induced ROS
production, in a manner analogous to the reduction in
ROS levels seen upon Scp1P depletion in S. cerevisiae.
Moreover, oxidative stress in diploid fibroblasts specifi-
cally upregulates SM22 expression via a TGF-b depen-
dent mechanism, contributing to the senescent
phenotype [38]. Reduction in SM22 levels would there-
fore tend to promote cell survival when cells are under
stress, such as in a tumour environment, and may also
contribute to increases in actin dynamics that favour
metastatic potential.
Conclusions
This study highlights some of the mechanisms for the
apparent anti-oncogenic effect of SM22 at the cellular
level. Others have found that the raised expression of
this protein is associated with transforming and anti-
transforming phenotypes but this is also known to be
the case for many other actin cytoskeleton associated
proteins, for example, gelsolin [39,40]. The present
study is especially interesting since the down regulation
of SM22 is associated with the appearance of podo-
somes, structures implicated in extracellular remodeling
and invasion. These results open the way to understand-
ing how these structures form and what the role of
SM22 and other genes are in this important process.
Methods
Western Blotting
SDS-PAGE and western blotting were carried out as
described previously [41]. Antisera against SM22a
(ab10135, Abcam plc) NP22, NP25 [42], tubulin (Sigma)
and actin (Sigma) were used for the detection of SM22
isoforms and for quantization of shRNA and RNAi
knockdown.
Cell Culture, Transfection, Immunofluorescence
Microscopy and Generation of Stable Cell Lines
REF52 [43] and PT67 (Clontech) cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) and PC3
cells [44] in RPMI 1640, each supplemented with 10%
foetal calf serum (FCS) (Invitrogen). All transfections
were performed using Lipofectamine (Invitrogen) at 70%
confluency with 2 μg of plasmid of interest per 35 mm
dish. For immunofluorescence microscopy, cells were
seeded on coverslips, and following treatment of trans-
fection were fixed with 3.7% paraformaldehyde for 10
minutes and permeabilised with 0.05% Triton X-100 in
PBS for 1 minute. Fixed cells were then incubated with
Alexa 488-conjugation Phalloidin (Molecular Probes) to
visualize F-actin, anti-SM22a antibody (ab10135, Abcam
plc), cortactin (4F11, Upstate). Images were captured
digitally by cooled CCD camera on a Leica DMIRE2
microscope. For the generation of stable cell lines, stable
transfected cells were first selected with relevant antibio-
tic 48 hours post transfection. Stable clones were then
selected.
Cell Motility Assay
For cell migration assays, cells were allowed to adhere to
35 mm dishes overnight, then transferred onto a 37°C
heated microscope stage within 5% CO2 chamber. Cell
movements were captured on 2.5 minute time-lapse
using a Leica DMIRBE microscope and Volocity soft-
ware. The migratory paths of individual cells were
tracked using ImageJ (version 1.38x) with Manual
Tracking PlugIns. Movement and velocity from the
initial point where calculated for each cell using Excel.
10 cells were analyzed for each triplicate independent
experiment per cell line. Matrigel-coated Boyden cham-
bers were purchased from BD Biosciences and cell inva-
sion assays were performed and analyzed according to
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the manufacturers instructions, and using 10% serum in
the lower chamber as chemoattractant.
RNA interference
Potential 21mer sequences to be used for RNAi of
SM22a were identified using the BBSRC Chick EST
database RNAi target sequence prediction tool http://





cloned into pSIREN retroviral vector (Clontech). This
vector was then transfected into the packaging PT67
cell line for production of retroviral SM22a siRNA vec-
tor. Target cells were infected twice with retrovirus
before selection with puromycin. Sense control was pre-
viously generated in Ref52 cells using sense DG siRNA
sequence [45]. Transient RNAi knockdown was achieved
using pSiren-DNR-dsRed (Clontech).
ROS Measurement
Control REF52, or SM22 depleted REF52 cells were
grown at subconfluent levels in serum containing media
as described above, or in media without serum for 24
and 48 hours. Following the indicated treatments, cells
were incubated with 2’,7’-dichlorodihydrofluorescein dia-
cetate (H2DCFDA, Invitrogen, Karlsruhe, Germany) at
200 μg/μl for 1 hour at 37°C, washed in PBS, trypsinised
and incubated with 100 μg/ml Propidium iodide (PI) for
15 minutes to visualize and exclude apoptotic/necrotic
cells. Treated cells were then collected in PBS and ana-
lyzed using a Cyan Flow Cytometer (DakoCytomation)
with Summit4.3 software.
Additional material
Additional file 1: REF52 stably expressing siRNA constructs directed
against SM22 show altered actin morphology. Similar to results with
REF52 cells transiently expressing SM22 RNAi (Figure 2 of main
manuscript), REF52 cells with a stable depletion of SM22 levels also
exhibited a qualitatively similar change in actin stress fibre organization
(A) and as defined for Figure 2 of the main manuscript, with an overall
reduction in stress fibre density and organization in cells lacking SM22, cf
Figure 2. B, representative western blot of SM22a levels in siRNA control
and depleted (KD) cells. C, quantization of stress fibre phenotypes in
wildtype REF52 cells (black bars), siRNA control cells (grey bars) or SM22a
depleted cells (white bars). Data are mean ± SEM or 3 independent
experiments. Knockdown * p < 0.02 compared to wild type and p <
0.001 compared to siRNA control. No significant difference between
knockdown and sense control (p > 0.05).
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